Obesity Clinical Trial
Official title:
What is the Effect of a Feedback Device on Weight Loss and Metabolic Measurements in Obese People With the Metabolic Syndrome?
The purpose of this study is to determine if a weight loss app (VA MOVE!® Coach App) along
with regularly scheduled telephone counseling, will motivate obese people with metabolic
syndrome to lose weight and improve the symptoms of the metabolic syndrome, compared to usual
weight loss approaches. This study will randomly assign participants to one of two groups,
interventional or control. The interventional group will use the app with phone coaching and
standard of care for weight loss. The control group will receive standard weight loss care
without the app and phone coaching. Weight loss motivation to adopt life-style changes to
maintain weight loss and quality of life between the two groups will be compared. The
metabolic syndrome (MetS) is a cluster of disorders including high blood pressure,
pre-diabetes, the tendency to carry body weight around the waist, and increased fat in the
blood. When these problems happen together, there is an increased risk for heart attack,
stroke, diabetes and certain cancers.
Although the metabolic syndrome is a serious condition, it can be treated with diet, weight
loss and increased activity. It can even be reversed using these lifestyle changes. Due to
poor success with routine short-term weight loss treatment (group and one-on-one counseling),
it is time to address the problem by a different method. Studies have shown feedback devices
and weight loss apps have been successful in weight loss and weight maintenance. They are
economical (many apps are free), and convenient to use, without attendance at group sessions.
Since weight loss is the corner stone for improvement in the symptoms of the MetS, this study
will offer a unique approach to support individuals who are committed to losing weight and
adopting a healthier lifestyle.
Numerous studies demonstrated that feedback via text messaging, and interaction through
social networking support groups, in addition to iPhone apps, are all more effective in
weight loss measures than group sessions at a hospital site. (Duncan et al., 2011; Greene,
Sacks, Piniewski, Kil, & Hahn, 2012; Shaw et al., 2013; Spring et al., 2013). The benefit of
these various methods is that they appear to accelerate weight loss and prevent weight
re-gain if employed long-term. With technology changing daily, these approaches must be
considered an essential adjunct to, or replacement for, traditional group counselling
sessions.
Obesity rates in the United States have steadily increased since the 1980's, doubling between
1980 and 2010 from 15.0% to 36.1% (Cefalu et al., 2015). The prevalence rate of obesity in
adults in the U.S. in 2014 was 37.7%, according to the Centers for Disease Control and
Prevention (CDC) National Center for Health Statistics (Ogden, Carroll, Fryar, & Flegal,
2015) resulting in a rising incidence of type 2 diabetes, heart disease, hypertension, and
some cancers (American Society of Clinical Oncology, 2014). Many contributors to the rise in
obesity rates are cited in the literature: socio-economic, urbanization, sedentary behavior
(Hruby & Hu, 2015), psychological and motivational factors (Byrne, Cooper, & Fairburn, 2003),
and ethnicity and gender (Ogden et al., 2015). ). According to research done by The Pew
Research Center (DeSilver, 2016), daily caloric intake by the average American in 2010 was
2,481 calories, about 23% more than in 1970.
As research into obesity continues, contributing factors include more than excessive dietary
intake and decreased physical activity. Obesity scientists and medical specialists view the
disorder as a systemic dynamic involving the brain, gut, liver, adipose tissue, hormones,
inflammation, and heredity (Cefalu et al., 2015). The condition, recognized by the American
Medical Association as a disease in 2011, resulted in obesity specialists and medical board
certification (American Board of Obesity Medicine, ABOM, 2013).
Though considered a disease in itself, obesity is a major contributor to preventable
morbidity and mortality, as well as to enormous health care costs (American Nurse
Practitioner Foundation, 2013). The estimated cost of obesity and the resultant
co-morbidities in the U.S. in 2015 was $190 billion. This figure represented 21% of total
U.S. healthcare costs (Hruby & Hu, 2015). Furthermore, the excess cost incurred by obese
individuals annually over the non-obese was $1,152 for obese men (for prescription drugs and
hospitalizations), and $3,613 for obese women (Hruby & Hu, 2015).
Nearly 35% of all adults and 50% of those over 60 years of age in the United States, have the
Metabolic Syndrome (MetS) (Aguilar et al 2015). This is especially disturbing since the
population over 60 years of age increases annually, due to the aging of America. Obesity and
the MetS are the underlying factors in most of the chronic illnesses prevalent today:
diabetes, cancer, inflammatory diseases, reduced immunity, heart disease, stroke, and
disability. It is clear that new, pragmatic, cost effective treatment to control the risk
factors and resultant morbidity and mortality, caused by this epidemic, must be aggressively
investigated. Employing apps developed for mobile phones is an obvious choice, if the data
can show evidence that this approach is effective. This is a prime area for nurse
practitioners to initiate research and to add to the scientific knowledge of obesity and its
sequelae (American Nurse Practitioner Foundation, 2013).
This will be the first study of its kind to examine changes in the metabolic markers of the
MetS, body composition and biometrics using a feedback device in the form of a weight loss
app. As such, it has the potential to provide clinicians with evidence based, adjunctive
treatment for this population. This study will provide the seeds for a longer study to
determine the feasibility of using feedback devices to reinforce healthy life styles and
continue or maintain the weight loss. In this way, the participant will be able to achieve
true health benefits and reduced risks of co-morbidities due to obesity and the MetS.
Comparison with a control group will determine if the treatment is more effective than
standard of care for this population.
Motivation and readiness to change:
It is important to assess motivation and readiness to change in individuals who wish to
achieve significant life style behavior changes (Ceccarini, M., et al., (2015). Studies have
shown that risk of disease development can motivate people to adopt new habits. In a
randomized study of weight loss in women at high risk for breast cancer, Hartman, et al
(2016) found that women at risk of developing breast cancer were motivated to improve health
through weight loss. Using weight loss technology (My Fitness Pal) and phone contact, this
intervention resulted in greater weight loss that that of the control group. They concluded
that combining technology supported by phone counselling was effective in weight loss as a
treatment for women at increased risk for breast cancer. There are no current studies of the
effect of motivation on weight loss in people with the metabolic syndrome. However, it is
plausible that given the risks of developing diabetes or heart disease, these people may be
more motivated to use the app and pursue weight loss to prevent complications of the MetS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |